| Literature DB >> 31614942 |
Yang Huang1,2,3, Zhengjin Jiang4, Jue Wang5,6, Guo Yin7,8, Kun Jiang9,10, Jiasheng Tu11, Tiejie Wang12,13.
Abstract
Mahonia bealei (Fort.) Carr. (M. bealei) plays an important role in the treatment of many diseases. In the present study, a comprehensive method combining supercritical fluid chromatography (SFC) fingerprints and chemical pattern recognition (CPR) for quality evaluation of M. bealei was developed. Similarity analysis, hierarchical cluster analysis (HCA), principal component analysis (PCA) were applied to classify and evaluate the samples of wild M. bealei, cultivated M. bealei and its substitutes according to the peak area of 11 components but an accurate classification could not be achieved. PLS-DA was then adopted to select the characteristic variables based on variable importance in projection (VIP) values that responsible for accurate classification. Six characteristics peaks with higher VIP values (≥1) were selected for building the CPR model. Based on the six variables, three types of samples were accurately classified into three related clusters. The model was further validated by a testing set samples and predication set samples. The results indicated the model was successfully established and predictive ability was also verified satisfactory. The established model demonstrated that the developed SFC coupled with PLS-DA method showed a great potential application for quality assessment of M. bealei.Entities:
Keywords: M. bealei; SFC fingerprint; chemical pattern recognition; quality evaluation
Mesh:
Substances:
Year: 2019 PMID: 31614942 PMCID: PMC6832872 DOI: 10.3390/molecules24203684
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Appearance characters of M. bealei samples and its substitutes. A: cultivated M. bealei; B: wild M. bealei; C: M. breviracema Y. S. Wang et Hsiao; D: M. duclouxiana Gagnep; E: M. bodinieri Gagnep; F: M. fordii Schneid.
Figure 2SFC fingerprints of different M. bealei samples and its substitutes. Experimental condition: NH2 (4.6 mm × 250 mm, 5 μm); mobile phase: (A) sCO2; (B) MeOH containing 0.4% (v/v) diethylamine and 8% (v/v) water; gradient: 015 min/18%–25% B, 15–20 min/25%–35% B. 20.1–25 min/18% B; injection volume: 5 μL; flow rate: 3.0 mL/min; column temperature: 28 °C; backpressure: 140 bar; detection wavelength: 230 nm; samples: S1–S27, S31, S34, S36, S39–S41, S46–S47, S49.
SA results of 37 batches of M. bealei samples and its substitutes.
| Sample | Similarity | Sample | Similarity |
|---|---|---|---|
|
| 0.942 |
| 0.936 |
|
| 0.942 |
| 0.870 |
|
| 0.955 |
| 0.871 |
|
| 0.952 |
| 0.898 |
|
| 0.957 |
| 0.861 |
|
| 0.964 |
| 0.862 |
|
| 0.976 |
| 0.875 |
|
| 0.862 |
| 0.850 |
|
| 0.909 |
| 0.912 |
|
| 0.910 |
| 0.913 |
|
| 0.941 |
| 0.841 |
|
| 0.968 |
| 0.912 |
|
| 0.830 |
| 0.896 |
|
| 0.913 |
| 0.952 |
|
| 0.956 |
| 0.980 |
|
| 0.973 |
| 0.954 |
|
| 0.982 |
| 0.973 |
|
| 0.928 |
| 0.955 |
|
| 0.929 |
Figure 3HCA dendrogram of different M. bealei samples and its substitutes.
Figure 43D score plot of PCA on the first three PCs for training set samples.
Figure 5VIP plot for training set samples based on PLS-DA method.
Figure 62D PLS-DA score plot of training set samples. Cluster 1 (green color): cultivated M. bealei; Cluster 2 (Blue color): wild M. bealei; Cluster 3 (red color): substitutes.
Figure 72D PLS-DA score plot of training set samples and testing set samples. Cluster 1 (green color): cultivated M. bealei; Cluster 2 (Blue color): wild M. bealei; Cluster 3 (red color): substitutes.
Prediction results for 26 batches of samples.
| Members | Correct | Cultivated | Wild | Substitutes | |
|---|---|---|---|---|---|
|
| 18 | 100% | 18 | 0 | 0 |
|
| 2 | 100% | 0 | 2 | 0 |
|
| 6 | 100% | 0 | 0 | 6 |
|
| 0 | / | 0 | 0 | 0 |
|
| 26 | 100% | 18 | 2 | 6 |
|
| 5.6 × 10−6 |
Detailed information of samples.
| Sample No. | Species | Origin | Specification |
|---|---|---|---|
| 1–12 | Guangxi | Crude drugs (cultivated) | |
| 13 | Yunnan | Crude drugs (cultivated) | |
| 14 | Anhui | Crude drugs (cultivated) | |
| 15 | Zhejiang | Crude drugs (cultivated) | |
| 16 | Jiangxi | Crude drugs (cultivated) | |
| 17 | Sichuan | Crude drugs (cultivated) | |
| 18–20 | Guizhou | Crude drugs (cultivated) | |
| 21–29 | Guangxi | Crude drugs (wild) | |
| 30–34 | Guangxi | Crude drugs (wild) | |
| 35–39 | Guangxi | Crude drugs (wild) | |
| 40–45 | Guangxi | Crude drugs (wild) | |
| 46–50 | Guangxi | Crude drugs (wild) | |
| 51–58 | Guangdong | Crude drugs (wild) | |
| 59–65 | Anhui | Crude drugs (cultivated) | |
| 66–72, 74–75, 79 | Jiangxi | Crude drugs (cultivated) | |
| 73 | Anhui | Crude drugs (cultivated) | |
| 76–78, 80–83 | Guangdong | Crude drugs (cultivated) | |
| 84 | Jiangxi | Crude drugs (cultivated) | |
| 85–86 | Anhui | Crude drugs (cultivated) | |
| 87–89 | Guangxi | Crude drugs (cultivated) |